AMT - Advanced Materials Technology / HALO Protein

HALO Protein

####MAGENTO-BREADCRUMBS####

HALO protein columns from AMT (Advanced Material Technology) are made of core-shell material and offer 400 Å and 1000 Å pore sizes for unrestricted pore access of large proteins. With these pore sizes and core-shell technology, ultra-fast and high-resolution separations can be achieved. The particles are available with a diameter of 2.7µm and 3.4µm and with ES-C18, C4 and diphenyl modifications.

 

####MAGENTO-PRODUCT-LINES####
####MAGENTO-CATEGORY-PRODUCTS####

Technical Data

Phase

Modification

Particle size

Pore size

Endcapping

C-content

USP

Surface area

pH range

Tmax

HALO Protein ES-C18

C18

2.7 µm
3.4 µm

1000 Å
400 Å

+

1.4 %C
1.0 %C

L1

15 m²/g

1.0-8.0

90°Ca
40°Cb

HALO Protein C4

C4

2.7 µm
3.4 µm

1000 Å
400 Å

+

0.6 %C
0.4 %C

L26

15 m²/g

2.0-9.0

90°Ca
40°Cb

HALO Protein Diphenyl

Diphenlmethyl

2.7 µm
3.4 µm

1000 Å
400 Å

+

N/A
1.0 %C

L11

15 m²/g

2.0-9.0

90°Ca
40°Cb

a Low pH; b High pH

Applications

Higher resolution with HALO 400 Å diphenyl compared to FPP 300 Å diphenyl

HALO 400 Å diphenyl outperforms an FPP 300 Å diphenyl column with higher resolution and 2.7 times lower back pressure. The 400 Å pores allow better access to the bound phase.

 

TEST CONDITIONS

  • Columns:
    HALO 400 Å Diphenyl, 3.4 μm, 2.1 x 150 mm
    FPP 300 Å Diphenyl, 1.8 μm, 2.1 x 150 mm
  • Flow rate: 0.2 mL/min
  • Temperature: 60 °C
  • Injection volume: 2 μL of 2 mg/mL denosumab
  • Instrument: Shimadzu Nexera
  • Detection: PDA at 220 nm
  • Mobile Phase A: 88/10/2 Water/ACN/n-Propanol + 0.1% DFA
  • Mobile Phase B: 70/20/10 n-Propanol/ACN/Water + 0.1% DFA
  • Gradient: 18-28% B in 20 min

High temperature comparison of the HALO 1000 Å phases

Three bound phases (C4, ES-C18 and diphenyl) are now available on surface porous HALO 1000 Å particles. Each phase offers unique selectivity for mAbs, as shown in this high temperature separation of trastuzumab.

 

TEST CONDITIONS

  • Columns:
    HALO 1000 Å C4, 2.7 μm, 2.1 x 150 mm
    HALO 1000 Å ES-C18, 2.7 μm, 2.1 x 150 mm
    HALO 1000 Å Diphenyl, 2.7 μm, 2.1 x 150 mm
  • Flow rate: 0.4 mL/min
  • Temperature: 80 °C
  • Injection volume: 2 μL with 2 mg/mL
  • Sample: trastuzumab in water/0.1% TFA
  • Instrument: Shimadzu Nexera
  • Detection: PDA at 280 nm
  • Mobile Phase A: Water/0.1% TFA
  • Mobile Phase B: ACN/0.1% TFA
  • Gradient:
    32-40% B in 16 min (C4 und ES-C18)
    32-38% B in 12 min (Diphenyl)

Comparison of HALO 1000 Å Diphenyl with the competitor product PolyPhenyl at 40 °C

HALO 1000 Å diphenyl shows improved resolution, retention and peak area compared to a competitor column of 450 Å SPPs with polyphenyl phase. The increased retention clearly shows the advantage of unhindered large pore access to the bound phase. The HALO diphenyl phase can also be operated at 40 °C without any loss of peak area.

 

TEST CONDITIONS

  • Columns:
    HALO 1000 Å Diphenyl, 2.7 μm, 2.1 x 150 mm
    SPP 450 Å PolyPhenyl, 2.7 μm, 2.1 x 150 mm
  • Flow rate: 0.4 mL/min
  • Temperature: 40 °C
  • Injection volume: 2 μL with 2 mg/mL
  • Sample: trastuzumab in water/0.1% TFA
  • Instrument: Shimadzu Nexera
  • Detection: PDA at 280 nm
  • Mobile Phase A: Water/0.1% TFA
  • Mobile Phase B: ACN/0.1% TFA
  • Gradient: 30-45% B in 15 min

Downloads

Brochures

Applications

Technical support

####MAGENTO-CONTACT-SECTION####